Department of Neurology,
UCLA Stroke Center,
Los Angeles, California
To the Editor:
I read with interest Hankey and Hon's recent review of studies of
surgery for primary intracerebral
hemorrhage.1 Their systematic review of case
series is a novel contribution to the literature. There is some
precedent, however, for their meta-analysis of extant
randomized controlled trials of surgical versus medical therapy. The
authors may have been unaware of my brief meta-analysis of the
same 4 trials, published 3 years earlier, as it appeared in a book
chapter rather than a Medline article.2 Contrasts between
the two meta-analyses are illuminating.
My formal systematic overview examined the clinical end point of
mortality rather than the combined clinical end point of death or
dependency used by Hankey and Hon. Collating all 4 studies, I found no
major effect of surgery, with an odds ratio of fatal outcome of 0.97
(95% confidence interval [CI], 0.64 to 1.48). This finding is
similar that of Hankey and Hon for the combined death or dependency end
point. Theirs is, I will add, the more clinically relevant end
point.
However, I additionally chose to cluster for separate analysis
the 3 modern, CT-era trials. Strong arguments can be made that the
large, early trial of McKissock et al,3 now 37 years old,
should not be mingled with the 3 later studies from the past decade.
McKissock and colleagues were not able to use CT scans for planning of
operative approach and did not have modern microsurgical techniques to
deploy intraoperatively. The surgical mortality rate in the McKissock
trial exceeded that of later studies by 15% to 23%. And because the
McKissock trial sample size was larger than that of the 3 later trials
combined, its data are likely to mask trends latent in the smaller,
modern studies.
Pooling results from the modern era studies of Juvela et
al,4 Auer et al,5 and Batjer et
al,6 I found a statistically significant benefit of
surgery on mortality, with odds of death of 0.50 (95% CI, 0.28 to
0.92). Employing Hankey and Hon's abstraction of data, pooled
analysis of these 3 studies for the end point of death or
dependency reveals a trend toward lower odds of death or dependency at
6 months (odds ratio, 0.72; 95% CI, 0.38 to 1.44).
These promising trends should encourage further clinical trials of
decompressive surgery for primary intracerebral
hemorrhage. Our current database is pitiably small, even in
pooled analysis. As Hankey and Hon note, a trial large enough
to definitively identify the benefits and risks of surgery is urgently
needed.
References
1.
Hankey GJ, Hon C. Surgery for primary
intracerebral hemorrhage: is it safe and
effective? Stroke.. 1997;28:21262132.
2.
Saver JL. Surgical therapy. In: Feldmann E, ed.
Intracerebral Hemorrhage. Armonk,
NY: Futura Publishing Co; 1994:303332.
3.
McKissock W, Richardson A, Taylor J. Primary
intracerebral hemorrhage: a controlled trial of
surgical and conservative treatment. Lancet.. 1961;2:221226.
4.
Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T,
Kaste M, Troupp H. The treatment of spontaneous
intracerebral hemorrhage: a prospective
randomised trial of surgical and conservative treatment. J
Neurosurg.. 1989;70:755758.[Medline]
[Order article via Infotrieve]
5.
Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert
R, Schneider G, Holzer P, Bone G, Mokry M, Korner E, Kleinert G,
Hanusch S. Endoscopic surgery versus medical treatment for spontaneous
intracerebral hematoma: a randomised study.
J Neurosurg.. 1989;70:530535.[Medline]
[Order article via Infotrieve]
6.
Batjer HH, Reich JS, Allen BC, Plaizier LJ, Jen Su C.
Failure of surgery to improve outcome in hypertensive putaminal
hemorrhage: a prospective randomised trial. Arch
Neurol.. 1990;47:11031106.
Stroke Unit,
Department of Neurology,
Royal Perth Hospital,
Perth, Western Australia
We thank Dr Saver for his interest in our paper and for drawing
our attention to his meta-analysis of the trials of surgery for
primary intracerebral hemorrhage,1
which we had not identified.
We agree that the trial of McKissock et al,2 carried out
in the pre-CT era, is now perhaps anachronistic, but we included it in
our overview because one of the principles of a sound
meta-analysis is to include all the evidence (ie,
randomized trials) and not just selective studies. Having done that,
however, we then examined the data from the 3 more recent trials in
which primary intracerebral hemorrhage was
diagnosed by CT brain scan. Because the combined sample size was so
small (only 85 in the control group and 84 in the surgically treated
group) and the 95% confidence intervals of the odds ratio (0.72) of
death or dependency so wide (ranging from 0.38 [surgery being very
effective] to 1.44 [surgery being harmful]), we elected not to
present this analysis in our paper. We did not carry out a
further analysis of the effect of surgery on mortality in the 3
CT-era trials but are interested to see Dr Saver's results, which
suggest that surgery may reduce the odds of death by 8% to 72%.
However, because these results are derived from a post hoc
analysis of a very small number of outcome events (death), they
are statistically unstable and imprecise, and hypothesis generating
rather than conclusive. Furthermore, the effect of surgery on
functional outcome among survivors is unknown. There remains
considerable uncertainty surrounding the risks and benefits of surgery
for primary intracerebral hemorrhage and the
need for more data from randomized controlled trials. The results of
Saver's analysis of the effects of surgery for primary
intracerebral hemorrhage on mortality should
not precipitate any ethical restraint on the conduct of future large
randomized controlled trials.
Since the publication of our article,3 we have been
informed that Prof David Mendelow and Dr M.S. Siddique at the
Department of Surgery (Neurosurgery), University of Newcastle, UK, have
initiated a multicenter (UK and Germany), randomized controlled trial
of surgery for primary intracerebral
hemorrhage. To date, 35 patients have been recruited, and the
target is 1000 patients. We congratulate them on this endeavor and wish
them well.
References
1.
Saver JL. Surgical therapy. In: Feldmann E, ed.
Intracerebral Hemorrhage. Armonk,
NY: Futura Publishing Co; 1994:303332.
2.
McKissock W, Richardson A, Tayloer J. Primary
intracerebral hemorrhage: a controlled trial of
surgical and conservative treatment. Lancet.. 1961;2:221226.
3.
Hankey GJ, Hon C. Surgery for primary
intracerebral hemorrhage: is it safe and
effective? Stroke.. 1997;28:21262132.
© 1998 American Heart Association, Inc.
Letters to the Editor
Surgery for Primary Intracerebral Hemorrhage: Meta-analysis of CT-Era Studies
Response
This article has been cited by other articles:
![]() |
A. A. Rabinstein, J. L. Atkinson, and E. F.M. Wijdicks Emergency craniotomy in patients worsening due to expanded cerebral hematoma: To what purpose? Neurology, May 14, 2002; 58(9): 1367 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kidwell, J. L. Saver, J. Mattiello, S. Warach, D. S. Liebeskind, S. Starkman, P. M. Vespa, J. P. Villablanca, N. A. Martin, J. Frazee, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage Neurology, November 13, 2001; 57(9): 1611 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Fernandes, B. Gregson, S. Siddique, and A. D. Mendelow Surgery in Intracerebral Hemorrhage : The Uncertainty Continues Stroke, October 1, 2000; 31(10): 2511 - 2516. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |